Equity Profile
Pre-Earnings Brief
Schein Henry Inc (HSIC) is a key player in the health care sector, specializing in the distribution of medical supplies and equipment. With a market cap of $9 billion, the company plays a crucial role in supporting healthcare providers and facilities, making it an important part of the health care supply chain.
EPS
Earnings per share (EPS) is a critical measure of profitability, reflecting the company's ability to generate profit for shareholders.
Revenue
Revenue indicates the total sales generated, which is essential for understanding the company's growth and market demand.
Wall Street expectations, options signals, track record, and call prep available with Pro.
EPS Beat Streak
2Q
EPS Beat Rate
75%
Avg EPS Surprise
+3.16%
Avg Stock Reaction
-0.30%
In the last quarter (Q4-2025), Schein Henry reported an EPS of $1.34, exceeding expectations and resulting in a positive stock reaction. The company has shown consistent performance, with a strong EPS surprise in previous quarters.
Management Promises & Guidance
Analysts expect Schein Henry to report solid earnings, with a consensus EPS of $1.22 and revenue of $3.3 billion. The company's history of beating earnings estimates may lead to positive market sentiment.
Bull Case
If Schein Henry beats EPS estimates, it could signal strong demand and operational efficiency, potentially driving the stock higher as investors gain confidence in its growth trajectory.
Bear Case
Conversely, if the company misses earnings expectations, it may raise concerns about market conditions or operational challenges, leading to a significant drop in stock price.
EPS
$1.22Earnings per share (EPS) is a critical measure of profitability, reflecting the company's ability to generate profit for shareholders.
Revenue
$3.3BRevenue indicates the total sales generated, which is essential for understanding the company's growth and market demand.
Expectations
The print will turn on these two things.
Q1
Will the EPS exceed $1.22, and if so, by how much?
A significant EPS beat could indicate strong operational performance and market demand, which would likely boost investor confidence.
Q2
What are the revenue figures, and how do they compare to the $3.3 billion consensus?
Revenue performance is critical to understanding the company's growth trajectory and market position, impacting future expectations.
Edge
Why consensus could be wrong
The Street may be underestimating the potential for Schein Henry to outperform due to its strong operational efficiencies and market demand.
Supporting Evidence
The company has consistently beaten EPS estimates in the past, indicating strong performance.
Recent industry trends suggest increased demand for medical supplies, which could benefit Schein Henry.
Management's focus on supply chain improvements may lead to better-than-expected results.
Key Risk
If revenue comes in below $3.3 billion, it could undermine the bullish outlook.
Edge
Pre-commit to what would confirm each case.
This quarter's performance will be closely watched as it reflects the company's ability to navigate market challenges and maintain profitability.
Bull Confirmed If
An EPS of $1.25 or higher would confirm the bull case, indicating strong profitability.
Bear Confirmed If
An EPS below $1.16 would confirm the bear case, suggesting potential operational issues.
Pre-Earnings Positioning
Implied Move
±4.2%
Historical Avg
±5.3%
The options market is pricing in a moderate move around the earnings announcement, reflecting uncertainty about the results.
Options are pricing ±4.0% while HSIC has averaged ±5.3% over the last 8 prints — setup is pricing cheap.
30d HV
20.0%
Preparation
Likely market behavior by outcome — not investment advice.
Beat & Raise
If Schein Henry beats expectations, history suggests the stock could rise by around 0.72% on the next trading day, confirming positive market sentiment.
In-Line / Cautious
An in-line report may lead to a muted reaction, as investors assess management's commentary for future guidance.
Miss
If the company misses expectations, history suggests a potential drop of about 7.41%, reflecting investor disappointment.
Preparation
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
LOEWS CORP